Edinburgh BioQuarter, GSK Partner for Pancreatitis R&D
BioWorld International Correspondent
LONDON – The new Edinburgh BioQuarter made the first step toward its aim of becoming Scotland's translational research hub, signing a drug discovery collaboration with GlaxoSmithKline plc in acute pancreatitis.
The deal follows a trawl by GSK as it hunts for 10 projects for its recently established university collaboration scheme, the Academic Discovery Performance Unit.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST